Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Impact of the COVID-19 Pandemic on Multidrug-Resistant Organism Infections in Infected Pancreatic Necrosis: A
Baiqi Liu1,2,3,4, Caihong Ning1,2,3,4, Jiarong Li1,2,3,4
1Department of Pancreatic Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
Background:
This study aimed to elucidate the impact of COVID-19 pandemic on multidrug-resistant organism (MDRO) infection in patients with infected pancreatic necrosis (IPN).
Methods:
This post-hoc analysis of a prospective cohort included patients with IPN stratified into three phases: pre-pandemic (2016-2019), pandemic period (2020-2022), and post-pandemic period (2023-2024). Logistic regression and interrupted time-series analysis (ITSA) were employed to identify risk factors and longitudinal trends.
Results:
MDRO infection decreased significantly during the pandemic period compared to pre-pandemic levels (44.8% vs 81.1%, P<0.001). There was no significant difference in the incidence of MDRO infection between the pandemic and post-pandemic period (44.1% vs 44.8%, P=0.924). During the pandemic, both prophylactic antimicrobial usage (64.8% vs 85.1%, P<0.001) and ICU stays (median: 6.0 vs 15.0 days, P<0.001) were significantly reduced compared to the pre-pandemic period. Logistic regression identified prophylactic antimicrobial usage (OR 17.28, P<0.001), ICU stays (OR 1.07, P<0.001), and the COVID-19 pandemic (OR 0.21, P<0.001) as independent factors associated with MDRO infection. ITSA revealed a significant decrease in the trend of MDRO infection during the pandemic compared to the pre-pandemic period (P=0.006). An immediate level of MDRO infection increased during the post-pandemic period compared to the pandemic (P=0.040). The similar trend variations were observed in the proportion of prophylactic antimicrobial usage.
Conclusion:
The COVID-19 pandemic has led to a notable reduction in MDRO infection among IPN patients, likely attributable to stringent infection prevention and control measures which led to reduced prophylactic antimicrobial usage and ICU stays during this period.
Insights
The COVID-19 pandemic significantly reduced multidrug-resistant organism (MDRO) infections in patients with infected pancreatic necrosis (IPN). This reduction was linked to decreased antimicrobial use and ICU stays during the pandemic.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Epidemiology
Background:
- The COVID-19 pandemic presented unique challenges to healthcare systems globally.
- Multidrug-resistant organism (MDRO) infections pose a significant threat, particularly in critically ill patients.
- Infected pancreatic necrosis (IPN) is a severe condition often associated with high rates of infection.
Purpose of the Study:
- To investigate the impact of the COVID-19 pandemic on MDRO infections in patients with IPN.
- To analyze trends in MDRO infection rates before, during, and after the pandemic.
- To identify factors influencing MDRO infection in IPN patients during different pandemic phases.
Main Methods:
- Post-hoc analysis of a prospective cohort of IPN patients.
- Stratification into pre-pandemic (2016-2019), pandemic (2020-2022), and post-pandemic (2023-2024) periods.
- Logistic regression and interrupted time-series analysis (ITSA) for risk factor and trend identification.
Main Results:
- MDRO infection rates decreased significantly during the pandemic (44.8%) versus pre-pandemic (81.1%).
- Prophylactic antimicrobial usage and ICU stays were reduced during the pandemic.
- The COVID-19 pandemic, reduced antimicrobial use, and shorter ICU stays were independently associated with lower MDRO infection rates.
Conclusions:
- The COVID-19 pandemic was associated with a substantial reduction in MDRO infections among IPN patients.
- Stringent infection control measures likely contributed to decreased antimicrobial use and ICU stays, thereby lowering MDRO rates.
- An increase in MDRO infection was observed in the post-pandemic period compared to the pandemic period.
More Related Videos
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

